InvestorsHub Logo
Followers 27
Posts 2968
Boards Moderated 0
Alias Born 04/14/2014

Re: snoof77 post# 107051

Monday, 04/27/2015 12:17:48 PM

Monday, April 27, 2015 12:17:48 PM

Post# of 123644
Exactly! But there are no revenues nor any anticipation or expectation of significant revenues let alone any at all. There isn't even any cash flow. Every new share issued is a 100% dilution of each share currently outstanding.

And remember this is not a new ground breaking technology or breakthrough Biotech stock looking at explosive growth. It's a no nothing, unbranded and unknown consumer product in a crowded space with no differentiation and tiny margins with a relatively high COG. And 2 billion shares out on MRIB is a HUGE number for a company that makes $2,000 a month. It's absurd to even consider MRIB an ongoing concern.

And this Brazil thing is also absurd. I have yet to hear any explanation of why or how MRIB could sell in Brazil when they can't sell in their own backyard? How's that going to happen? If the product doesn't sell here it won't sell there. That's just fact.